Get the Stockscreener App
14.94
1.97%
-0.30
Range Cancer Therapeutics ETF Stock (CNCR) Price History
The historical daily chart and data for Range Cancer Therapeutics ETF stock (CNCR), show that the latest closing stock price as of May 10, 2024, is $14.94.
- Range Cancer Therapeutics ETF all-time high stock price is $35.82, occurred on February 08, 2021.
- The lowest Range Cancer Therapeutics ETF stock price recorded was $0.00 on September 06, 2022. Since then, Range Cancer Therapeutics ETF's stock price has risen over to $14.94 now.
- The 52-week high stock price for CNCR is $17.96, representing a 20.21% increase from the current share price, occurred on March 01, 2024.
- The 52-week low stock price for CNCR is $9.22, indicating a -38.29% decrease from the current share price, occurred on October 27, 2023.
- The closing price of Range Cancer Therapeutics ETF (CNCR) stock in the beginning of 2023 was $24.15. The stock closed the year at $13.79, a loss of over -42.90% for the year.
The table below shows more information about CNCR historical price data:
Daily
Weekly
Monthly
7D
30D
60D
YTD
1Y
| Date | High | Low | High - Low | Volume | % Change |
|---|---|---|---|---|---|
| May 10, 2024 | $15.37 | $14.86 | $0.51 | 2,335.0 | -1.97% |
| May 09, 2024 | $15.50 | $15.01 | $0.49 | 4,504.0 | -1.42% |
| May 08, 2024 | $15.54 | $15.41 | $0.1299 | 2,779.0 | -2.09% |
| May 07, 2024 | $15.79 | $15.65 | $0.14 | 961.0 | +0.32% |
| May 06, 2024 | $15.88 | $15.67 | $0.21 | 4,463.0 | -0.76% |
| May 03, 2024 | $15.91 | $15.70 | $0.21 | 5,955.0 | +2.79% |
| May 02, 2024 | $15.61 | $15.24 | $0.365 | 11,035.0 | -0.06% |
| May 01, 2024 | $15.83 | $14.94 | $0.89 | 82,840.0 | +4.61% |
| Apr 30, 2024 | $15.10 | $14.76 | $0.34 | 15,808.0 | -1.80% |
| Apr 29, 2024 | $15.27 | $14.65 | $0.62 | 21,509.0 | +4.45% |
| Apr 26, 2024 | $14.43 | $13.94 | $0.4902 | 3,231.0 | +3.15% |
| Apr 25, 2024 | $14.26 | $13.77 | $0.49 | 6,377.0 | -1.97% |
| Apr 24, 2024 | $14.53 | $14.23 | $0.295 | 2,207.0 | -1.73% |
| Apr 23, 2024 | $14.65 | $14.44 | $0.2104 | 2,466.0 | +1.90% |
| Apr 22, 2024 | $14.48 | $14.05 | $0.43 | 6,832.0 | +0.71% |
| Apr 19, 2024 | $14.49 | $13.92 | $0.57 | 14,963.0 | -1.74% |
| Apr 18, 2024 | $14.63 | $14.36 | $0.27 | 1,766.0 | -1.44% |
| Apr 17, 2024 | $14.89 | $14.57 | $0.32 | 225,723.0 | -0.68% |
| Apr 16, 2024 | $15.00 | $14.67 | $0.33 | 30,018.0 | -2.27% |
| Apr 15, 2024 | $15.59 | $15.00 | $0.5888 | 17,928.0 | -4.03% |
| Apr 12, 2024 | $15.91 | $15.32 | $0.589 | 4,447.0 | -1.94% |
| Apr 11, 2024 | $16.00 | $15.67 | $0.329 | 4,864.0 | +2.57% |
| Apr 10, 2024 | $15.68 | $15.40 | $0.2829 | 9,477.0 | -2.81% |
Range Cancer Therapeutics ETF Stock (CNCR) Year by Year Price History
In this detailed analysis, we present a comprehensive overview of the price movements of Range Cancer Therapeutics ETF stock over the years. By exploring the year-by-year data, investors can gain valuable insights into the historical performance and volatility of CNCR shares. From significant milestones and fluctuations to notable trends, this in-depth examination of Range Cancer Therapeutics ETF stock price history provides a foundation for understanding how the company's stock has evolved over time.
Range Cancer Therapeutics ETF Stock (CNCR) Price History 2024
| Month | High | Low | High - Low | Volume | % Change |
|---|---|---|---|---|---|
| May, 2024 | $15.91 | $14.86 | $1.05 | 114,872.0 | +1.22% |
| Apr, 2024 | $16.59 | $13.77 | $2.82 | 444,906.0 | -11.19% |
| Mar, 2024 | $17.96 | $15.75 | $2.21 | 1,553,505.0 | -3.76% |
| Feb, 2024 | $17.73 | $14.19 | $3.54 | 417,271.0 | +21.96% |
| Jan, 2024 | $14.73 | $13.14 | $1.59 | 125,311.0 | +5.12% |
Range Cancer Therapeutics ETF Stock (CNCR) Price History 2023
| Month | High | Low | High - Low | Volume | % Change |
|---|---|---|---|---|---|
| Dec, 2023 | $13.93 | $10.78 | $3.15 | 129,629.0 | +22.40% |
| Nov, 2023 | $11.17 | $9.52 | $1.65 | 46,598.0 | +13.69% |
| Oct, 2023 | $10.84 | $9.22 | $1.62 | 101,046.0 | -11.64% |
| Sep, 2023 | $12.27 | $10.90 | $1.37 | 21,559.0 | -8.86% |
| Aug, 2023 | $12.90 | $11.80 | $1.10 | 45,719.0 | -7.11% |
| Jul, 2023 | $13.44 | $12.33 | $1.11 | 79,608.0 | +0.15% |
| Jun, 2023 | $14.04 | $12.70 | $1.34 | 157,265.0 | -2.78% |
| May, 2023 | $13.90 | $12.80 | $1.10 | 311,701.0 | +5.07% |
| Apr, 2023 | $13.16 | $11.77 | $1.39 | 285,603.0 | +5.50% |
| Mar, 2023 | $13.55 | $11.68 | $1.87 | 80,135.0 | -10.86% |
| Feb, 2023 | $15.18 | $13.27 | $1.91 | 54,051.0 | -9.42% |
| Jan, 2023 | $15.15 | $13.47 | $1.68 | 57,435.0 | +7.68% |
Range Cancer Therapeutics ETF Stock (CNCR) Price History 2022
| Month | High | Low | High - Low | Volume | % Change |
|---|---|---|---|---|---|
| Dec, 2022 | $15.28 | $13.08 | $2.20 | 107,472.0 | -7.51% |
| Nov, 2022 | $15.82 | $14.23 | $1.59 | 56,785.0 | -0.60% |
| Oct, 2022 | $15.43 | $14.05 | $1.38 | 276,875.0 | +2.37% |
| Sep, 2022 | $16.28 | $0.00 | $16.28 | 250,934.0 | -5.51% |
| Aug, 2022 | $18.01 | $15.26 | $2.75 | 89,685.0 | -2.76% |
| Jul, 2022 | $17.05 | $15.16 | $1.89 | 170,725.0 | +4.29% |
| Jun, 2022 | $15.86 | $12.76 | $3.10 | 184,590.0 | +9.85% |
| May, 2022 | $16.09 | $13.08 | $3.01 | 109,573.0 | -10.07% |
| Apr, 2022 | $19.36 | $15.31 | $4.05 | 82,267.0 | -14.02% |
| Mar, 2022 | $18.83 | $16.28 | $2.55 | 134,138.0 | -2.33% |
| Feb, 2022 | $19.76 | $17.20 | $2.56 | 221,486.0 | -4.92% |
| Jan, 2022 | $24.20 | $17.66 | $6.54 | 217,750.0 | -18.55% |
0.28%
0.17%
Cap:
|
Volume (24h):